Information  X 
Enter a valid email address

RedxPhar Ord 1p (REDX)

Related News

11-Mar-2020 08:11 AM

Redx Pharma posts annual loss as it develops drug candidates

Pharmaceutical group Redx Pharma posted a full-year loss as it continued to develop its oncology and fibrosis treatment candidates. Pre-tax losses for the year through September amounted to £6.3m, compared to losses of £10.1m on-year. Revenu
31-Dec-2019 08:29 AM

Redx Pharma in discussions over possible bid

Drug discovery and development firm Redx Pharma said it is in discussions over a possible cash offer from an investor group led by biotech industry figure Sam Waksal. The company said the announcement did not amount to a firm intention to make an offer a
19-Nov-2018 08:17 AM

Redx Pharma swings to loss; to kick off new clinical trial in 2019

Oncology and fibrosis-focused drug developer Redx Pharma swung to an annual loss after emerging from administration in November and slashing its headcount. The company also announced that it had appointed James Mead as its chief financial officer, replac
30-May-2018 08:39 AM

Redx Pharma losses halve after exiting adminstration

Cancer and fibrosis drug development group Redx Pharma said its first-half losses halved after it exited administration in November and re-focused its R&D efforts to cut costs. Pre-tax losses amounted to £4.9m, compared to £11.0m of red ink a
20-Dec-2017 08:16 AM

Redx Pharma swings from loss to profit

Redx Pharma reported a profit of £1.528m (2016: loss £15,521m) in the year ended 30 September 2017. In an extraordinary 12 months, the company entered Administration in May 2017 and then, post period in November 2017, successfully exited as a
03-Nov-2017 03:00 PM

Redx Pharma, Redx Oncology resume trading

Redx Pharma and Redx Oncology have confirmed that they have both now resumed trading after joint administrators filed their Final Report in the administrations of the Companies at Court and with the Registrar of Companies. The Board said it expects to ma
20-Apr-2017 01:22 PM

All resolutions passed at Redx AGM

Redx Pharma has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 1:22pm: (LON:REDX) Redx Pharma Plc Ord 1p share price was +0.13p at 36p Story provided by
20-Apr-2017 09:06 AM

Redx Pharma appoints Iain Ross as chairman

Redx Pharma has appointed Iain Ross as chairman of its Board of Directors and as a Non-Executive Director of the Company, effective from May 1. At 9:06am: (LON:REDX) Redx Pharma Plc Ord 1p share price was +0.13p at 36p Story provided by StockMarket
28-Feb-2017 01:03 PM

Redx shareholders approve equity issue

Redx has announced that, at the General Meeting held earlier today, all resolutions proposed were passed and as a result 26,779,958 new ordinary shares of 1p each will be admitted to trading on 1 March 2017. At 1:03pm: (LON:REDX) Redx Pharma Plc Ord 1
13-Apr-2016 12:12 PM

Redx shareholders approve equity issue

Redx has announced that all resolutions proposed at today's General Meeting were duly passed. As a result, 285,714 and 22,105,518 ordinary shares of 1 pence each in the Company will be admitted to trading on 14 and 15 April, respectively. At 12:
01-Oct-2015 07:27 AM

Redx's H2

Redx Pharma has continued to make good progress over H2 and noted the group's expenditure remains in line with budgets. FY total operating income is anticipated to be £2.8m, from £2.0m in the six months to March 31. FY cash balance is seen at abo
Top categories
Company finder

a d v e r t i s e m e n t